Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of 245.95 million. The enterprise value is 688.46 million.
| Market Cap | 245.95M |
| Enterprise Value | 688.46M |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 339.77M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.55% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 3.83% |
| Float | 333.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| PB Ratio | 0.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.39 |
| P/OCF Ratio | 3.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.58, with an EV/FCF ratio of 15.09.
| EV / Earnings | -13.19 |
| EV / Sales | 1.05 |
| EV / EBITDA | 4.58 |
| EV / EBIT | 8.60 |
| EV / FCF | 15.09 |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 1.71.
| Current Ratio | 2.49 |
| Quick Ratio | 0.90 |
| Debt / Equity | 1.71 |
| Debt / EBITDA | 3.82 |
| Debt / FCF | 12.73 |
| Interest Coverage | 1.39 |
Financial Efficiency
Return on equity (ROE) is -14.36% and return on invested capital (ROIC) is 5.12%.
| Return on Equity (ROE) | -14.36% |
| Return on Assets (ROA) | 3.80% |
| Return on Invested Capital (ROIC) | 5.12% |
| Return on Capital Employed (ROCE) | 6.84% |
| Revenue Per Employee | 228,144 |
| Profits Per Employee | -17,997 |
| Employee Count | 2,900 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 3.73 |
Taxes
In the past 12 months, Cresco Labs has paid 45.44 million in taxes.
| Income Tax | 45.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.36% in the last 52 weeks. The beta is 1.89, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.89 |
| 52-Week Price Change | -43.36% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 28.89 |
| Average Volume (20 Days) | 932,748 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of 661.62 million and -52.19 million in losses. Loss per share was -0.15.
| Revenue | 661.62M |
| Gross Profit | 316.69M |
| Operating Income | 80.94M |
| Pretax Income | -5.22M |
| Net Income | -52.19M |
| EBITDA | 132.79M |
| EBIT | 80.94M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 45.41 million in cash and 580.76 million in debt, giving a net cash position of -535.35 million.
| Cash & Cash Equivalents | 45.41M |
| Total Debt | 580.76M |
| Net Cash | -535.35M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 340.17M |
| Book Value Per Share | 1.20 |
| Working Capital | 145.27M |
Cash Flow
In the last 12 months, operating cash flow was 74.94 million and capital expenditures -29.33 million, giving a free cash flow of 45.62 million.
| Operating Cash Flow | 74.94M |
| Capital Expenditures | -29.33M |
| Free Cash Flow | 45.62M |
| FCF Per Share | n/a |
Margins
Gross margin is 47.87%, with operating and profit margins of 12.23% and -7.89%.
| Gross Margin | 47.87% |
| Operating Margin | 12.23% |
| Pretax Margin | -0.79% |
| Profit Margin | -7.89% |
| EBITDA Margin | 20.07% |
| EBIT Margin | 12.23% |
| FCF Margin | 6.89% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.55% |
| Shareholder Yield | -2.55% |
| Earnings Yield | -21.22% |
| FCF Yield | 18.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.47 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.47 |
| Piotroski F-Score | 5 |